Sanofi-adr (SNY) — Who's Buying and Selling (13F, Q2 2026)

SNY ranks #748 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

SNY is a top-conviction position for Regal Partners Ltd — at 6.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in SNY belongs to Dodge & Cox, but the position matters far more to Regal Partners Ltd, who has 6.3% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

JPMorgan has added to its SNY position for two straight quarters, increasing it by $139.6M to reach $285.5M today.

Dodge & Cox has trimmed its SNY position for two straight quarters, cutting it by $1.5B while still holding $1.2B.

SNY is down 0% today, and institutions have been net sellers of $763.4M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

SNY closed its latest fiscal year with net income of $7.9B.

• Profitable — net income of $7.9B in the latest fiscal year
• Net income improved year over year, from $5.6B to $7.9B
• Generated $10.8B in positive operating cash flow
• Liabilities run 0.02x equity — within a conventional range